M.A. van der Pol

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

N Feller, M.A. van der Pol, Amber van Stijn et al. · Leukemia · 2004 · 182 citations · Full text

Hematological Malignancy, Oncology, Immunophenotypic Detection Methods +13

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome

N Feller, Gerrit Jan Schuurhuis, M.A. van der Pol et al. · Leukemia · 2003 · 64 citations

Cell Therapy, Medicine, Poor Clinical Outcome +12

A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia

Amber van Stijn, Alice Kok, M.A. van der Pol et al. · Leukemia · 2003 · 26 citations · Full text

Hematological Malignancy, Flow Cytometric Method, Medicine +15

Minimal Residual Disease in Acute Myeloid Leukemia Is Predicted by an Apoptosis-Resistant Protein Profile at Diagnosis

Amber van Stijn, N Feller, Alice Kok et al. · Clinical Cancer Research · 2005 · 23 citations · Full text